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Abstract: (1) Background: Sleep disorders are a common problem for public health since they are
considered potential triggers and predictors of some mental and physical diseases. Evaluating the
sleep quality of a person may be a first step to prevent further health issues that diminish their
independence and quality of life. Polysomnography (PSG) is the “gold standard” for sleep studies,
but this technique presents some drawbacks. Thus, this study intends to assess the capability of the
new Xiaomi Mi Smart Band 5 to be used as a tool for sleep self-assessment. (2) Methods: This study
will be an observational and prospective study set at the sleep unit of a hospital in A Coruña, Spain.
Forty-three participants who meet the inclusion criteria will be asked to participate. Specific statistical
methods will be used to analyze the data collected using the Xiaomi Mi Smart Band 5 and PSG.
(3) Discussion: This study offers a promising approach to assess whether the Xiaomi Mi Smart Band
5 correctly records our sleep. Even though these devices are not expected to replace PSG, they may
be used as an initial evaluation tool for users to manage their own sleep quality and, if necessary,
consult a health professional. Further, the device may help users make simple changes to their habits
to improve other health issues as well. Trial registration: NCT04568408 (Registered 23 September
2020).
Keywords: sleep; health promotion; daily life activities; occupation; polysomnography; Xiaomi Mi
Smart Band 5; wearable technology; participatory health; internet of things
1. Introduction
Sleep is an occupational area that has considerable implications on our daily life [1,2].
Thus, sleep disorders have become one of the most important common problems in public
health [3]. The prevalence of sleep disorders increases with age [4], even though they can
appear at any life stage. Bad quality and quantity of sleep, sleep arousals, and a strong
will to take diurnal naps are the main complaints among the general population [5,6].
Epidemiological studies indicate that between 20% and 48% of adults between 34 and 60
years old have difficulties initiating and maintaining sleep [7]. In fact, insomnia, which is
the most common sleep disorder, is present in 30–45% of the population [8].
Several studies state that sleep disorders are related to health status and quality of
life in the general population [9], leading to difficulties in the performance of daily life
activities, which in turn causes physical exhaustion, low productivity, a greater risk of
falling, mood problems, and diurnal sleep, among many others [10–14].
These factors related to sleep disorders cause a direct and indirect economic burden,
causing public health costs to rise [15,16]. Different studies have shown a direct relation
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between sleep disorders and costs in primary care and hospitals. Lee et al. indicated that
the population suffering from sleep disorders regularly attends the emergency room to
consult professional health workers, or demands telematic assistance [9]. This is due to
subjective complaints of sleep, along with factors related to stress, working pressure, and
other chronic diseases [17,18].
Diverse sleep disorders are diagnosed using different tests that assess the quality
and quantity of sleep [19,20]. Objective and valid diagnostic tests that evaluate the qual-
ity and quantity of sleep are a previous requisite for the control of sleep disorders [21].
Polysomnography (PSG) is considered by the scientific community as the most reliable test
for the measurement of sleep parameters [22,23]. However, it has some clear drawbacks,
such as its costs, operation, invasiveness, and time needed for its use [24,25]. To address
these problems, actigraphy technology was designed. Actigraphy consists of the measure
of sleep parameters using a wearable device created for clinical use [26]. Several studies
have found similar measures from both actigraphy and PSG, proving its fitness for these
studies [27–29]. Although actigraphy has become a clinically useful tool to test sleep dis-
orders, it cannot provide feedback to people because it purpose is mainly of a research
nature [26]. Thus, inspired by the actigraphy device, researchers have recently focused on
the validation of different tools for sleep self-assessment, such as activity wristbands [30].
In recent years, activity wristbands have become widely accepted among the popula-
tion due to their low price, easy use, smart design, and feedback that they offer to users
through their fast sync with smartphones, boosting participatory health [31–33]. These
devices have already reported benefits in clinics, as they reduce care burdens and facilitate
the early diagnosis of health disorders [34]. They also allow the general population to
acquire information on their sleep quality and physical activity, which may help in the
early detection or prevention of symptoms related to sleep alterations [35–37].
Despite being limited, some studies highlight the importance of the validation of these
devices not only from a technological point of view, but also for health promotion, since,
by allowing sleep self-assessment, they are tightly related to improvements in life quality
and daily functioning [38–41].
Recent studies have compared the measurements of these wristbands with those of
actigraphy and PSG techniques. PSG involves different types of electrodes (electroen-
cephalogram (EEG), electrooculogram (EOG), electromyogram (EMG), and electrocardio-
gram (ECG)) to classify the stages of sleep [42]. A few studies have shown that the usability
of an ECG signal can determine the stages of sleep [43–46]. Nevertheless, some have
considered the need for further research due to the insufficient quality of this classification
compared to the combination of the other electrodes [47,48].
In general, wearable devices can determine the stages of sleep through a heart rate
(HR) sensor, which measures the HR, and an accelerometer that detects movement. Pre-
viously validated wearable devices have shown a high precision and sensitivity, but also
a low specificity and poor agreement in sleep-stage classification when compared with
PSG [20,32,33,49,50]. It would be logical to expect these devices to measure sleep more
accurately; however, according to these studies, there is a wide range of improvements that
can still be accomplished [51,52]. As a result, this protocol has been designed to validate
the Xiaomi Mi Smart Band 5 due to its low cost and high acceptance among users, as it is
the best-selling fitness tracker [53]. This device has the capability of tracking the activity
and HR of users, and classifies the user’s state as being awake or in light sleep, deep sleep,
or REM sleep [54].
Therefore, this research focuses on determining whether sleep stages recorded by the
new Xiaomi Mi Band 5 can effectively replace PSG sleep-stage classification in sleep-study
participants. To this end, the following features will be calculated for both devices: total
sleep time, sleep efficiency, sleep latency, and wake after sleep onset. Sleep stages will also
be recorded.
Int. J. Environ. Res. Public Health 2021, 18, 1106 3 of 10
Thus, the primary purpose of the present study is to validate the quality of the data
generated by Xiaomi wearables when compared with the PSG technique from a hospital
sleep unit.
The secondary objectives are: (1) to determine the total sleep time, sleep efficiency,
sleep latency, and wake after sleep onset from both the wearable device and PSG; and
(2) to examine whether the classification of sleep stages provided by wearable devices is
comparable with classifications based on PSG.
2. Materials and Methods
2.1. Study Design
This is a pilot study that aims “to demonstrate that the expected measures, data
collecting instruments, and their management system are viable and effective” [55]. This
is an observational and prospective study, which means that different variables from the
population of interest will be observed and recorded without any direct intervention, in
order to establish causality associations between these variables. It will be considered a
longitudinal study, with a timeframe of six months, in which participants will stay one
night at the sleep unit. They will be monitored to record their sleep through PSG and the
Xiaomi wristband.
This study protocol follows the SPIRIT 2013 checklist for study protocols for clinical
trials (See File S1) [56].
2.2. Study Settings
The setting of this study will be the sleep unit of a hospital in A Coruña, Spain. This
service includes a special consulting room where different sleep disorders are diagnosed
and treated. Some of these disorders are sleep apnea, insomnia, restless-legs syndrome,
narcolepsy, the delay and advance of sleep stages, sleep terrors, somnambulism, and
bruxism. The sleep laboratory is equipped to perform different diagnostic tests: noc-
turnal and diurnal PSG, multiple latency tests, immobilization tests, and wakefulness
maintenance tests.
2.3. Eligibility Criteria
Sample selection will be performed through an intentional sampling based on inclu-
sion and exclusion criteria.
Participant inclusion criteria: (a) having attended the sleep unit to have any diagnostic
test done; (b) having declared an age that is equal to or higher than 18 years old.
Participant exclusion criteria: (a) having a significant health complication that hinders
active participation in the study; (b) suffering from skin hypersensitivity or an allergic
reaction due to the materials of the wristbands that will be used in the study.
2.4. Recruitment Process
This project will be conducted in the sleep unit of a hospital that, regardless of this
study, people attend to have PSG tests done with the aim of detecting possible alterations
in their sleep. The participants will be assisted by, at a minimum, the clinical neurophys-
iologist responsible for the sleep unit and a member of the research team. In the first
meeting with each of the users, the clinical neurophysiologist responsible for recruiting
the participants and monitoring them will inform them, if they meet the selection criteria,
about the possibility of participating in the study and the implications of their participation,
i.e., the use of an activity bracelet during the day or night and what is involved in the PSG
test that will be performed on them. In addition, the mechanisms that will be followed to
guarantee their anonymity and the confidentiality of their data will be clearly stated to
the participants.
After the main characteristics of the research have been explained, each potential
participant will be given an information sheet so that they can consult the information
and make a decision before the test is carried out. Once the users return to the unit for
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testing, any doubts or queries will be resolved by the clinical neurophysiologist, and the
informed consent document will be signed, if applicable, by the responsible professional
and the person who expresses their final interest in participating in the study. In addition,
if the participant has reading and writing difficulties, a witness must be present during
the entire procedure to confirm that all the ethical processes have been respected by the
research team. On the day of the PSG test, participants will arrive three hours before the
test to become acquainted with the room, and will turn the lights on and off based on their
sleep pattern. The specialized technical staff will control the test and will attend to any
possible patient demands. Figure 1 shows the recruitment and the assessment process.
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2.5. Justification of Sample Size
Differences equal or greater than 15 min in deep-sleep time between the measures of
both methods are considered clinically relevant. Accepting a 0.05 alpha risk and a 0.1 beta
risk (90% power) in a bilateral contrast, 43 subjects are needed to detect a differe ce that
is equal to or greater than 15 min. Conservatively, a standard deviation of 30 for mean
differences is assumed, according to previous studies [21,50,57].
2.6. Outcomes
The outcomes will be the sleep-stage identification of PSG and the Xiaomi Mi Smart
Band 5, and measurements of total sleep time, sleep efficiency, sleep latency, and wake
after sleep onset.
2.7. Data Collection and Management
The study will focus on examining the following variables (Table 1): time in bed, hours
of light, deep and Rapid-Eye-Movement (REM) sleep, sleep efficiency, sleep latency, wake
after sleep onset, and HR. Additionally, the Pittsburgh Sleep Quality Index (PSQI) scale
and a sociodemographic questionnaire will be used to assess participants’ self-awareness
of their sleep.
Table 1. Summary of the features of interest for our study.
Variable Description Dimension
Time in bed (TIB) Total time the patient is laying down min
Sleep onset latency (SOL) Length of time from full wakefulness to sleep min
Wake after sleep onset (WASO) Periods of wakefulness after defined sleep onset min
Sleep efficiency (SE) Time asleep/TIB × 100 %
Light sleep N1 + N2 sl ep stages min
Deep sleep N3 sleep stages min
Rapid Eye Movement (REM)
sleep - min
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The sociodemographic questionnaire will collect different data: gender, year of birth,
weight, height, handedness, sleep pathologies, and the assessment test. These data will
be pseudonymized and transferred by the hospital to the research group with the prior
consent of the participant.
The PSQI will evaluate subjective sleep quality. This questionnaire consists of 24 items
about the area of sleep. This tool analyzes the quantity, quality, duration, latency, and
efficiency of sleep [58].
The objective sleep data will be obtained through two different devices:
Xiaomi Mi Smart Band 5: This is a wearable device focused on health and sport that
measures biomedical parameters of users, among which HR and sleep measurements are
the most remarkable. The wristband also requires certain personal data from the user
to precisely calculate the activity, such as age, height, weight, gender, handedness, and
wristband location. Wristband data will be obtained from the Mi Fit application, which is
the native app of the Xiaomi Mi Band wristband. It is necessary to connect the wristband
via Bluetooth to a smartphone of general use for the group, creating generic emails for each
of the wristbands. The features of interest will be calculated from the data shown in this
app [32].
PSG: Data obtained from diurnal and nocturnal PSG will be collected, as this is the
standard test for patients who attend to the hospital’s sleep unit. PSG measures sleep
cycles and stages (N1, N2, N3, and REM sleep) by recording different variables, such as
brain waves, eye movement, skeletal muscle activity, heart frequency and rhythm, blood
pressure, oxygen level in the blood, breathing patterns, body position, limb movements,
and whether there is snoring or other noise [59]. PSG parameters will be scored in 30 s
epochs according to the American Academy of Sleep Medicine (AASM) guidelines [60], and
PSG recordings will be exported in the European Data Format+ format [61] and interpreted
by a doctor specialized in the study of sleep. Thus, sleep-stage classification based on PSG
will be considered the “gold standard” for this study.
The data will be pseudonymized at the moment they are recorded; thus, the confi-
dentiality of the data collected and the anonymity of each participant will be maintained.
Once the project has ended, each participant’s data will be stored for future studies if they
provide consent.
2.8. Data Analysis
The analysis will be performed by using the statistical software R. Numeric variables
will be expressed as mean (M) and standard deviation (SD), including the range, minima,
and maxima. Beyond simple data and study variable descriptions, inferential analysis will
be performed in order to determine possible significant relationships between the variables
of the study.
A paired-sample Student’s t-test will be used to compare the means of the different
sleep parameters of interest. T-test effect sizes are 0.2 (small effect), 0.5 (moderate effect),
and 0.8 (large effect), so if the means of two groups do not differ by a 0.2 standard deviation,
the difference is trivial, even if there is a statistically significant relationship. [62]. Bland–
Altman plots will be used to assess the concordance between both devices for each of the
sleep parameters (total sleep time, sleep efficiency, and wake after sleep onset). A positive
bias indicates that the device tends to underestimate a variable when compared with PSG.
A negative bias indicates that a sleep variable is overestimated [63]. Point estimations will
be calculated, as well as their 95% confidence interval.
An epoch-by-epoch (EBE) (min × min) analysis will be performed in order to calculate
the sensitivity (the proportion of epoch segments identified as a sleep state by the PSG that
are correctly identified by Xiaomi), specificity (the proportion of epoch segments identified
as a waking state by the PSG that are correctly identified by the Xiaomi wristband), and
the level of agreement between both devices for light sleep identification (the proportion
of PSG-classified N1 + N2 stages identified as light sleep by the Xiaomi wristband), deep
sleep identification (the proportion of PSG N3 + N4 stages identified as deep sleep by
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the Xiaomi wristband), and REM sleep identification (proportion of PSG-classified REM
stages identified as REM sleep by the Xiaomi wristband) [64]. Data analysis will include
the cleaning or preprocessing, description, and processing of the stored data. The final aim
of this workflow will be to obtain useful information that can be used for decision-making.
During preprocessing, the wrong values of the dataset will be removed or corrected to avoid
bias in the results. Subsequently, obtaining a descriptive statistic study that summarizes
relations and distributions in a simple way will help us to know which processing strategy
needs to be taken. When processing, information extraction will be performed.
2.9. Ethics and Dissemination
This study protocol was approved by the A Coruña-Ferrol Research Ethics Committee,
under the number 2020/318, on 20 July 2020. In addition, this protocol was registered in
Clinical Trials Protocol Registration and Results system on 23 September 2020, available
at https://clinicaltrials.gov/ct2/show/NCT04568408. In case any change in the protocol
is needed, this will be communicated to the ethics committee with the assigned reference
number. These modifications will also be updated in the clinical trials registry.
For each participant, the process of informed consent will be applied. Participants
will receive complete verbal and written information about the characteristics of the study
and about the implications derived from their participation in it. An information sheet
that they can read slowly will be given to each participant, and they will be able to ask any
questions they may have. Once it has been ensured that all participants fully understand
the information provided, they will decide on whether or not they wish to participate
in the study and, if they decide to participate, agree by signing the informed-consent
document. The main researcher will maintain the confidentiality of all data collected and
the anonymity of each participant. Thus, the Spanish and European Organic Law on the
protection of personal data will be respected at all times [65,66]. The data of the participants
will be collected, encoded, and preserved until the end of the study. Once the study is
finished, each participant’s data will be stored for future studies if they provide consent.
The results and conclusions of this study will be disseminated through their publication in
influential scientific journals and their presentation at appropriate conferences.
3. Discussion
The validation conducted in this study will allow us to evaluate whether the Xiaomi
Mi Smart Band 5 is a device that can be used as a health promoter by allowing sleep
self-assessment in the general population. Due to its low price, it is fairly accessible to any
user who considers that they may be suffering from a sleep disorder that is potentially
worsening their health [32]. Hence, if the data generated by the smart band proves to be
reliable, any health professional could evaluate at a glance whether the user is suffering
from a sleep disorder, and whether it influences their daily life activities [40,67]. The
widespread use of these devices could help users to self-assess their sleep and connect with
health professionals in the case of bad sleep quality, which would imply a better prognosis
and a longer and higher-quality life expectancy. It is important to highlight some limitations
and risks in studies focused on the validation of wearables, since firmware updates may
modify the sleep-tracking algorithm, and the intra-wearables’ sleep measurements do not
perfectly match, even when multiple smart bands worn by the same user are identical.
4. Conclusions
This project contributes to the validation of the sleep data obtained through the Xiaomi
MiBand 5, making a comparison with the PSG data. Therefore, it is intended to determine
whether the sleep parameters (TIB, SOL, WASO, SE, light sleep, deep sleep and REM sleep)
are correctly measured through the Xiaomi MiBand 5.
The widespread use of these devices by the current society is not expected to replace
the PSG. However, the information obtained by the wristbands about sleep is user-friendly
in a domestic context, as this sleep data doesn’t need to be processed as in the case of
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the PSG. Thus, the use of these devices can help the population to be able to objectively
determine whether they have difficulties in their sleep or not, as well as to promote healthy
lifestyle habits, and if necessary, seek the advice of a healthcare professional.
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